Dr Shahla Vilcassim

Learn more about Monash Health’s Haematology team.

Dr Shahla Vilcassim

Dr Shahla Vilcassim a clinical and laboratory haematologist at Monash Health with a special interest in malignant haematology, in particular MDS. She is also part of the Monash Haemoglobinopathy Service with an interest in thalassaemia and bone marrow failure syndromes. She is currently completing her PhD at the Hudson Institute of Medical Research where she is looking at the role of iron dysregulation in the Myelodysplastic syndromes.

Shahla is the Cancer at Home medical lead as part of the Adult Hospital in the Home Program at Monash Health.

Publications

Vadolas J, Ng G, Kysenius K, Crouch P, Dames S, Eisermann M, Nualkaew T, Vilcassim S, Schaeper U, Grigoriadis G. SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia. Br J Haematology May 2021

Tedjaseputra A, Vilcassim S, Grigoriadis G. Ocular infiltration as initial presentation of acute monocytic leukaemia transformed from chronic myelomonocytic leukaemia with BRAF V600E mutation. BMJ Case Rep. March 2019

Chee A, Low MS, Vilcassim S, Gregory GP, Gilbertson M, Ratnasingam S, Grigoriadis G, Fedele PL. Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma. Br J Haematology. August 2017

Vilcassim S, Low M, Fedele P, Grigoriadis G. Periorbital papules as a presenting sign in multiple myeloma with AL amyloidosis. BMJ Case Rep. Feb 2017

Low MS, Vilcassim S, Fedele P, Grigoriadis G. Acute monocytic leukemia masked by hemolytic anemia and sclerotic lesions. Annals of Hematology.  2016 Dec